Why the study?
Does levosimendan improve right ventricular hemodynamic performance in patients with intractable cardiogenic shock following myocardial infarction?
Does levosimendan improve right ventricular hemodynamic performance in patients with intractable cardiogenic shock following myocardial infarction?
In patients with post-myocardial infarction cardiogenic shock refractory to conventional inotropes, bail-out levosimendan therapy significantly improves right ventricular hemodynamic performance.
Answers are grounded in this paper and cite their sources.
Was associated with improved RV hemodynamics in refractory post-MI shock; leaves open need for randomized outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ruß et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: